Solal CBD Drops 15ml
Mood and sleep support
Unlike delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD) does not activate the cannabinoid type 1 (CB1) and cannabinoid type 2 (CB2) receptors. This is thought to explain its lack of psychotropic effects.
CBD has some antidepressant effects. These effects may be explained by CBD’s facilitation of endocannabinoid activity, facilitation of 5HT1A receptor activity, and/or facilitation of hippocampal neurogenesis.
CBD has been shown to modulate tumor necrosis factor (TNF)-alpha, interleukin (IL)-1, and interferon (IFN)-gamma and suppress chemokine production, which attributes to its anti-inflammatory properties.
The following mechanisms may explain CBD’s anxiolytic effects: activation of 5HT1A receptors, facilitation of endocannabinoid system, enhancement of hippocampal neurogenesis, and/or activation of TRP channels.
SOLAL CBD Drops are specially formulated to assist with mood and sleep support, stress relief and inflammation. Thanks to the addition of Medium Chain Trigylceride (MCT) oil, which is a quick-digesting saturated fatty acid, SOLAL CBD Drops absorb and metabolise far more efficiently to deliver a calming and tranquil effect on mind and body. This unique formulation does not contain Tetrahydrocannabinol (THC) making it safe for use without concerns of psychoactive effects.
Each 0,5 ml contains:
DL-alpha tocopheryl acetate, medium chain triglyceride (MCT) oil.
Preservative: DL-alpha tocopheryl acetate (Vitamin E).
Suitable for vegans and vegetarians.
Adults 18 years and older: Take 0,5 ml (20mg) daily, or as directed by healthcare professional. Take with or shortly after a meal for best absorption.
Do not use this product if you are hypersensitive (allergic) to any of the ingredients. If you are on any medication or suffering from any medical condition, it is advisable to seek medical advice before starting any new medicine, supplement or remedy.
Do not exceed recommended dosage(s) unless on the advice of a healthcare practitioner.
This product may lead to drowsiness and impaired concentration, which may be aggravated by simultaneous intake of alcohol or other central nervous system depressants.
This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.